- DKK101.26bn
- DKK126.40bn
- $3.72bn
Europe Research Roundup: Allianz, Koninklijke Philips, St. James's Place
Focus: Drugmakers turn to AI to speed trials, regulatory submissions
Brief: Genmab Says Net Sales Of Darzalex In 2025 $14,351 Mln
Genmab shares fall after cancer drug trial failed to meet endpoint
Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage study (updated)
NASDAQ RESUMED AT 01:50 PM
Brief: Genmab Says Phase 3 Trial For Epcoritamab Did Not Reach Statistical Significance
Genmab's blood cancer drug fails main goal in late-stage study
NASDAQ TRADE HALT HALT NEWS PENDING AT 12:55 PM
Brief: Genmab Partners With Anthropic To Accelerate Research And Development Through Agentic AI
Brief: Genmab Partners With Anthropic To Accelerate R&D Via Agentic AI
Genmab scraps development of experimental cancer therapy
Brief: Genmab: Completion Of Tender Offer For Outstanding Common Shares Of Merus N.V.
Brief: Genmab Shares Encouraging Early-Stage Data On Epcoritamab For RT Patients
Brief: Genmab Announces Data From Multiple Clinical Trials
Brief: Genmab Presents Phase 3 Data from EPCORE FL-1 Trial
Europe Research Roundup: Auto1 Group, Roche Holding, Sanofi
Brief: Genmab Announces Pricing Of Private Offering Of Senior Secured Notes And Senior Unsecured Notes
Brief: Genmab Announces Proposed Private Offerings